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Abstract This study aimed at directly assessing glucose 6-
phosphate (G6P) transport by intact rat liver microsomes.
Tracer uptake from labeled G6P occurred with T1=2 values that
proved insensitive to unlabeled G6P or 100 WM vanadate, and
could not be activated over background levels by intravesicular
phosphate in the complete absence of G6P hydrolysis.
[32P]Phosphate efflux was similarly unaffected by G6P or
phosphate in the incubation medium. We conclude that the gene
product responsible for glycogen storage disease type Ib is
functionally distinct from the bacterial hexose phosphate
transporter, which operates as an obligatory phosphate:phos-
phate or G6P:phosphate exchanger. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Liver glucose 6-phosphatase (G6Pase) is tightly linked to
the endoplasmic reticulum membrane, where it plays a crucial
role in carbohydrate metabolism by controlling glucose pro-
duction from glucose 6-phosphate (G6P) hydrolysis [1]. The
absence of enzyme activity is associated with a class of meta-
bolic disorders known as glycogen storage diseases type I
(GSD-I): the most frequent form (GSD-Ia) is caused by a
de¢ciency in the catalytic unit protein (p36), while a variant
(GSD-Ib) would arise from impaired function of its associated
putative G6P translocase (p46) [2].
The G6P transport function currently attributed to p46
mostly stems from its homology with the bacterial upper hex-
ose phosphate transporter (UhpT) [1] and is mainly supported
by circumstantial pieces of evidence [3^5]. In this respect,
carriers related to the UhpT protein were also termed ‘Pi-
linked’ because in each case Pi (inorganic phosphate) is ac-
cepted with relatively low a⁄nity while some selected organic
phosphate substrate is accepted with high a⁄nity [6]. In con-
trast, all experiments aimed at testing G6P transport in intact
microsomes have so far been performed in the absence of Pi
on the trans side [3^5]. In the present study, we demonstrate
that p46 does not function as a G6P translocase and appears
functionally distinct from its bacterial UhpT counterpart.
2. Materials and methods
2.1. Materials
[U-14C]G6P (317 mCi mmol31) was purchased from ICN Biomed-
icals, while [32P]G6P (144 mCi mmol31) was prepared as previously
described [7]. KH2PO4, G6P, mannose 6-phosphate, phlorhizin,
chlorogenic acid, and sodium orthovanadate were from Sigma.
2.2. Microsome preparation
Liver microsomes were isolated from overnight-fasted male
Sprague^Dawley rats (approx. 300 g body weight), as previously de-
scribed [7], using bu¡er A (50 mM HEPES^Tris, 250 mM sucrose, pH
7.3) during the homogenization and resuspension steps. If necessary,
microsomes were permeabilized by detergent treatment as reported in
[8].
2.3. Enzyme and protein assays
G6Pase and mannose 6-phosphatase activities were measured at
room temperature, as previously described [7], and the microsomal
preparations routinely displayed more than 90% latency relative to
mannose 6-phosphate. Vanadate inhibition of G6Pase activity was
tested following a 3-min period of incubation in the presence of the
indicated concentrations of inhibitor. Protein was assayed as reported
in [9].
2.4. Uptake measurements
The kinetics of tracer uptake were followed at room temperature
using a fast-sampling, rapid-¢ltration apparatus (FSRFA; US patent
No. 5 330 717) developed in our laboratory [10]. Microsomes were
preincubated for 3 min in bu¡er A supplemented or not with 0.1
mM or 5 mM vanadate, as indicated. When using Pi-loaded micro-
somes, the preincubation media also contained 25 mM KH2PO4. Up-
take measurements were performed in 1 ml bu¡er A containing 10
WM [32P]G6P or [U-14C]G6P, and either unlabeled G6P or various
inhibitors, as indicated. In£ux experiments were started by injecting
40 Wl of microsomes (approx. 0.8 mg protein) into the incubation
chamber of the FSRFA. For e¥ux measurements, the microsomes
and incubation media were mixed prior to their introduction into
the chamber; following a 2-min period of incubation, e¥ux was ini-
tiated by injecting 40 Wl of bu¡er A alone or bu¡er A plus unlabeled
G6P or KH2PO4, as indicated. In both cases, the tracer content of the
vesicles was followed in time by 18-point automatic sequential sam-
pling and liquid scintillation counting, as previously described [7].
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2.5. Data analysis
Three to ¢ve uptake series were run under each of the reported
experimental conditions. In£ux and e¥ux data were analyzed by Enz-
¢tter or P. Fit software (both published and distributed by Biosoft)
according to the ¢rst-order rate equation
U  U0 Ur13e3kt 1
or the single exponential decay equation
U  U0e3kt Ur 2
respectively. Note that the parameters U, U0, and Ur stand for the
intravesicular amounts of tracer at time (t), at time zero, and at equi-
librium, respectively, whereas k is the ¢rst-order rate constant of the
uptake process from which the T1=2 values (i.e. the time at which 50%
of the process has been completed) reported in this paper have been
calculated (T1=2 = ln 2/k). Note that the errors associated with the
kinetic parameter values represent standard error of regression
(S.E.R.), which result from weighted or unweighted non-linear regres-
sion analysis of the data.
3. Results and discussion
3.1. Tracer uptake from [32P]G6P
Tracer uptake from [32P]G6P was completely suppressed
following detergent treatment and upon incubation with
5 mM of either chlorogenic acid or phlorhizin (Fig. 1A), two
speci¢c inhibitors of the putative T1 G6P translocase [11,12].
Our microsomal preparations thus appear fully functional
with regard to the expected role of p46. However, as depicted
in Fig. 1B, over the ¢rst 2-min period of incubation, tracer
uptake from [32P]G6P occurred with T1=2 values that proved
insensitive to unlabeled G6P (see Table 1), which acts as a
competitive inhibitor of tracer G6P transport and hydrolysis.
This result does not prove that p46 does not act as a glucose
6-phosphate translocase, provided that [32P]Pi rather than
[32P]G6P is the main labeled species to be found in the intra-
microsomal space. In this regard, the mean T1=2 þ S.E.M.
(standard error of the mean; value of 32P uptake (17.1 þ 0.5
s, see Table 1) closely matches that previously reported for
[32P]Pi e¥ux (22 þ 3 s, see [13]), in accordance with the dem-
onstration that the rates of tracer accumulation observed in
such studies should re£ect those of Pi e¥ux [13]. Moreover,
using [14C]G6P as the labeled substrate, it was shown that the
steady-state level of tracer molecules is directly proportional
to G6Pase activity [9], and that G6P at best represents a tiny
fraction of the intramicrosomal glucose pool independently of
whether a substrate transport or conformational model is con-
sidered [13]. The lower steady-state values of 32P uptake, ob-
served in Fig. 1B, at increasing concentrations of unlabeled
G6P clearly conform to these conclusions. Therefore, these
data challenge the contention of Lei et al. [4] and Hiraiwa
et al. [5] that tracer uptake from labeled G6P characterizes
G6P transport.
3.2. Tests of G6P:32Pi and Pi :32Pi exchange activities
The rationale behind the following series of experiments is
that the existence in the microsomal membranes of G6P:Pi
and/or Pi :Pi exchange activities should lead to increased rates
of [32P]Pi e¥ux in the presence of unlabeled G6P and/or Pi in
the trans compartment. Note that the low concentration of 10
WM [32P]G6P used in these studies was chosen to maximize
the sensitivity of the assays. As depicted in Fig. 1B, over the
last 2-min period of incubation, microsomes actively loaded
with [32P]Pi by 2 min incubation with 10 WM [32P]G6P were
challenged by the addition of either various concentrations of
unlabeled G6P or 20 mM Pi (not shown) to the incubation
media. Compared to bu¡er addition alone, unlabeled G6P
(and Pi) initiated [32P]Pi e¥ux through competitive inhibition
of [32P]G6P hydrolysis, as inferred from the similar steady-
state values observed under symmetrical in£ux and e¥ux con-
ditions [9]. However, the T1=2 values of [32P]Pi e¥ux proved to
Table 1
T1=2 þ S.E.R. values of [32P]Pi equilibration
Experimental conditions In£ux E¥ux
10 WM G6P (control) 16.4 þ 1.1 ^
1 mM G6P 16.4 þ 2.8 16.9 þ 3.7
5 mM G6P 16.9 þ 3.4 16.6 þ 2.7
10 mM G6P 18.5 þ 4.3 17.4 þ 2.1
20 mM Pi ^ 18.4 þ 1.6
Experimental conditions and analyses were as described in the
legend of Fig. 1.
Fig. 1. Tracer uptake from [32P]G6P, and test of G6P:32Pi exchange
activity. In A, the uptake media consisted of 1 ml bu¡er A contain-
ing 10 WM [32P]G6P (b), and either 0.8% 3-[(3-cholamidopropyl)-di-
methylammonio]-2-hydroxy-1-propanesulfonate (a), 5 mM phlorhi-
zin (R), or 5 mM chlorogenic acid (E). In B, in£ux experiments
were performed as described in (A) in the absence (b) or presence
of either 1 mM (E) or 5 mM (R) unlabeled G6P. For e¥ux, micro-
somes were incubated for 2 min in the control medium, and then
challenged by bu¡er addition alone (a) or in combination with un-
labeled G6P to get either 1 (F) or 5 (O) mM G6P in the ¢nal mix-
ture. The dotted lines represent the extrapolated plateau values
under in£ux conditions. In A and B, the solid lines shown for in£ux
and e¥ux are the best-¢t curves to Eqs. 1 and 2 in the text, respec-
tively, with T1=2 values as reported in Table 1. Missing error bars
were smaller than the symbol size.
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be insensitive to outside G6P and Pi, and similar to those
given above for 32P uptake (mean T1=2 þ S.E.M. value of
17.4 þ 0.4 s, see Table 1). It can be concluded then that micro-
somal G6P transport appears functionally distinct from
UhpT, which operates as an obligatory G6P:phosphate or
phosphate:phosphate exchanger [6]. In this regard, a recent
study from our lab also failed to demonstrate 32Pi :Pi ex-
change activity when measured under zero-trans entry condi-
tions in the absence of G6P hydrolysis [13].
3.3. Tests of [14C]G6P transport and [14C]G6P:Pi exchange
activity
The most serious limitation to studies aimed at evaluating
the kinetics of G6P transport in intact microsomes is the ever-
present G6Pase activity, which does not allow us to directly
assess the relative contributions of intravesicular substrate and
product pools to the dynamics of the uptake process [13].
Accordingly, complete and speci¢c inhibition of p36 activity
would be desirable to directly assess the putative transport
functions associated with p46. In this respect, a similar Ki
value of approx. 20 WM was recently reported for orthovana-
date inhibition of G6Pase activity in intact and detergent-dis-
rupted microsomes [14], thus supporting the concept that p36
rather than p46 is the target of vanadate action. In line with
this view, vanadate was shown to inhibit the steady-state level
of intramicrosomal tracer accumulation from labeled G6P
without a measurable e¡ect on T1=2 [9], and to o¡er no pro-
tection against N-ethylmaleimide alkylation of sulfhydryl res-
idues that qualify to represent important thiol groups on p46
[15]. Furthermore, vanadate did not inhibit glucose or Pi
transport when measured under zero-trans in£ux conditions
[13] or from e¥ux studies in which microsomes were actively
loaded with [14C]glucose or [32P]Pi by prior incubation with
[14C]G6P [9] or [32P]G6P [13], respectively.
The experiments depicted in Fig. 2 corroborate, at a G6P
concentration of 1 mM and room temperature, that G6P hy-
drolysis rather than transport is the target for vanadate inhi-
bition of tracer uptake. Indeed, 100 WM vanadate did not
a¡ect the rate of tracer uptake (T1=2 = 80 þ 4 or 83 þ 4 s in
the absence or presence of vanadate, respectively; see Fig.
2A), while inhibiting steady-state tracer accumulation and
G6P hydrolysis by 52 þ 4% (Fig. 2A) and 60 þ 13% (Fig.
2B), respectively. Fig. 2 further demonstrates that a concen-
tration of vanadate as high as 5 mM is needed to completely
inhibit tracer uptake and G6P hydrolysis under symmetrical
conditions.
Using this saturating concentration of inhibitor, Fig. 3 al-
lows us to establish that similar levels of tracer uptake are
observed in vanadate- and detergent-treated microsomes dur-
ing the whole 1-h period of these studies. Therefore, tracer
uptake in vanadate-treated vesicles represents non-speci¢c
binding of [14C]G6P to the microsomal membranes, which
amounts at 60 min of incubation to approx. 6% of the total
water space of 5 Wl mg31 protein [13] accessible to substrate
transport. As also shown in Fig. 3, the rate of tracer uptake
was not increased in Pi-loaded microsomes under experimen-
tal conditions aimed at minimizing any potential competition
between outside [14C]G6P and Pi for transport (both [14C]G6P
and Pi were present at a ¢nal concentration of 1 mM in the
uptake media). Therefore, in the complete absence of G6Pase
Fig. 2. E¡ect of vanadate on the kinetics of radiotracer accumula-
tion from [U-14C]G6P (A) and on G6Pase activity (B). In A, the
uptake medium consisted of 1 ml bu¡er A containing 1 mM
[U-14C]G6P and either 0 (b), 0.1 (F), or 5 (R) mM orthovanadate.
The best-¢t curves corresponding to Eq. 1 in the text are shown for
control (Ur = 4.18 þ 0.01 nmol mg31 protein, k = 0.0087 þ 0.0004
s31) and 0.1 mM vanadate (Ur = 2.17 þ 0.01 nmol mg31 protein,
k = 0.0084 þ 0.0004 s31). In B, G6Pase activity was assayed using
symmetrical conditions of incubation and the indicated concentra-
tions of orthovanadate. The line shown is the best-¢t curve when
assuming competitive inhibition (I50 = 67 þ 15 WM). In A and B,
missing error bars were smaller than the symbol size.
Fig. 3. Tests of [14C]G6P transport and [14C]G6P:Pi exchange activ-
ities. Rat liver microsomes were ¢rst preincubated in bu¡er A con-
taining either 0.8% 3-[(3-cholamidopropyl)-dimethylammonio]-2-hy-
droxy-1-propanesulfonate (a), 5 mM vanadate (R), or 5 mM
vanadate plus 25 mM KH2PO4 (O). Uptake conditions were as de-
scribed in the legend of Fig. 2A.
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activity, p46 does not exhibit [14C]G6P:Pi exchange activity
and does not function as a G6P translocase. We thus chal-
lenge the contention of Fulceri et al. [3] that the swelling
phase observed upon G6P addition to rat liver microsomes
characterizes G6P transport rather than intravesicular accu-
mulation of glucose and Pi produced by G6P hydrolysis. In-
deed, this conclusion mostly rests on the observation that
similar results were obtained in the absence or presence of
100 WM vanadate, which was claimed, in contrast to the re-
sults depicted in Fig. 2, to inhibit up to 94% of enzyme ac-
tivity at a G6P concentration of 25 mM.
4. Conclusions
The present study demonstrates that p46 does not function
as a G6P translocase and appears functionally distinct from
its bacterial UhpT counterpart, which was shown to catalyze
the electroneutral exchange of internal and external Pi in ad-
dition to heterologous exchange of Pi and G6P [6]. This con-
clusion ¢ts in with our recent suggestion that a pore-like
structure takes on the Pi transport function usually attributed
to the putative T2 phosphate translocase in intact microsomes
[13]. It also proves consistent with the redundant observation
that approx. 90% of the total glucose or Pi produced during
the course of the enzyme reaction in intact microsomes does
not cycle through the intravesicular space [13,16], which in-
validates a major postulate of the substrate transport-catalytic
unit concept [12]. In this respect, then the GSD-Ib gene prod-
uct cannot be viewed as a G6P transport protein in the clas-
sical sense advocated by this theory. From the demonstration
that proper functioning of the G6Pase system does require the
simultaneous presence of p36 and p46 in the endoplasmic
reticulum membrane [4,5], we therefore suggest that p46 might
instead represent a G6P sensor protein modulating the previ-
ously characterized hysteretic transition that brings the
G6Pase system into a less competent catalytic form for the
pro¢t of higher substrate speci¢city [7]. In support of this
view, uncoupling between the p36 and p46 proteins has
been readily documented in the past in detergent-permeabi-
lized microsomes [11] and in intact preparations following
histone II-A treatment [17,18].
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